Anti-VEGF therapy has been a godsend for many patients with diabetic macular edema. But it’s not the whole answer for all patients. Greater personalization is still needed.
All content on the Academy’s website is protected by copyright law and the Terms of Service. This content may not be reproduced, copied, or put into any artificial intelligence program, including large language and generative AI models, without permission from the Academy.